Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
FDA's principal deputy to depart agency—Chutes & Ladders
FDA’s principal deputy to depart agency. Cozadd’s Jazz coda. Neutrolis pulls experienced execs for leadership team.
Darren Incorvaia
,
Zoey Becker
Dec 20, 2024 8:30am
FDA hits pause on another of PepGen's muscular dystrophy trials
Dec 16, 2024 9:45am
FDA hits Kezar's zetomipzomib with 2nd clinical hold in 2 months
Nov 13, 2024 5:22am
AstraZeneca, Daiichi pull lung cancer BLA for Enhertu follow-up
Nov 12, 2024 5:27am
FDA places Rapport's nerve damage trial on hold
Nov 7, 2024 8:50am
Lykos accepts FDA view that MDMA med needs new trial for approval
Oct 21, 2024 8:31am